Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a recent heart attack (such as a STEMI or NSTEMI) within the past 30 to 120 days, or a mini-stroke or stroke caused by a blockage in a nearby large blood vessel, confirmed by ultrasound, CT, or MRI scan
- People whose symptoms are stable and whose body is coping well without urgent medical intervention
- People aged 18 or older
- People who have agreed to take part and signed a consent form
Who may not be able to join:
- People whose recent heart or stroke event is thought by their specialist to have been caused by a travelling blood clot (embolism) rather than a blockage in a blood vessel
- People with severely reduced heart pumping function (the heart is working at less than 30% of its normal capacity)
- People with serious heart valve problems that need surgical or procedural treatment
- People with heart failure that is not currently under control
- People who are pregnant (women who could become pregnant will need to have a negative pregnancy test before joining)
- People who are breastfeeding
- Women who could become pregnant and are unwilling to use two forms of contraception throughout the study, or men who could father a child and are unwilling to use contraception
- People who are unable to give their own informed consent
- People who have a known allergy to a substance called Florbetaben, which is used in the imaging part of the trial
- People whose kidneys are not working well enough (kidney function below a certain level measured by a GFR test)
- For the CT scan with contrast dye portion of the trial: people with a dye allergy, or those with a slightly higher kidney function threshold, will not have that particular scan — but may still be able to have the PET/CT scan instead (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kevin E Boczar, MD, Ottawa Heart Institute Research Corporation
Phone: 6132821835
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of using 18F-Florbetaben PET in patients with recent ACS or stroke/TIA to detect inflammatory plaque
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.